Marchex (MCHX): Director received 50K units
Donald Cogsville, Director at Marchex, reported a grant / award of 50K units.
- 50K
- Derivative units
- Traded
- Dec 16, 2025
- Filed
- Dec 17, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 16, 2025Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On October 16, 2025 (the “Grant Date”), the Compensation Committee of the Board of Directors of Marchex, Inc. (the “Compensation Committee”), pursuant to its review of compensation for executive officers of the Corporation, approved updated annual base salaries of $400,000 for Troy Hartless, Marchex’s President and Chief Revenue Officer; $375,000 for Francis Feeney, Marchex’s Chief Operating Officer and Chief Legal…”
- Nov 13, 2025Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results
- Dec 16, 2025Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement (and 1 more item)“On December 16, 2025, Marchex held its 2025 annual meeting of stockholders (the “Annual Meeting”). Holders of Class A common stock are entitled to twenty-five (25) votes per share and holders of Class B common stock are entitled to one (1) vote per share and vote together as a single class on all matters (including election of directors) submitted to a vote of stockholders, unless otherwise required by law.”
What came next
- Jan 29, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On January 29, 2026, the Compensation Committee of the Board of Directors of Marchex, Inc., pursuant to its review of compensation matters for executive officers, approved annual cash bonuses for fiscal year 2025 of $200,000 to Troy Hartless, Marchex’s President and Chief Revenue Officer; $150,000 to Francis Feeney, Marchex’s Chief Operating Officer, Chief Legal Officer, and Corporate Secretary; and $40,000 to Brian…”
- Feb 17, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On February 17, 2026 (the “Grant Date”), the Compensation Committee of the Board of Directors of Marchex, Inc. (the “Corporation”), pursuant to its annual review of compensation matters, approved restricted stock units (“RSUs”) grants under the Corporation’s 2021 Stock Incentive Plan of 128,205 RSUs to Troy Hartless, Marchex’s President & Chief Revenue Officer; 96,153 RSUs to Francis Feeney, Marchex’s Chief…”
- Mar 25, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Marchex
OQRO holds no insider, Congress, fund or contract record for Marchex dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCHX page.
How this filing works
Explore the data
Other disclosures at Marchex
- SEC Form 4Mar 27, 2025
- SEC Form 4Mar 27, 2025
- SEC Form 4Mar 27, 2025
- SEC Form 4Nov 19, 2024
- SEC Form 4Nov 19, 2024
- SEC Form 4Nov 15, 2024
Everything OQRO holds on this company is on its MCHX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
